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ABSTRACT
Background: Despite the recent introduction of a number
of technical and pharmacologic blood conservation measures,
bleeding and allogeneic transfusion remain persistent problems in open-heart surgical procedures. Efforts should be
made to decrease or completely avoid transfusions to avoid
these negative reactions.
Methods: Our coronary artery bypass grafting database
was reviewed retrospectively and a total of 243 patients who
underwent cardiac surgery with cardiopulmonary bypass
(CPB) were studied in a 12-month period (January-December
2016) after the implementation of the new program, and compared with 275 patients of the previous 12-month period.
All the staff involved in the care of the patients were educated about the risks and benefits of blood transfusions and
the new transfusion guidelines in a 45-min training. We
revised our guidelines for transfusions based on the STS. A
transfusion log was created. Reduction in IV fluid volume
was targeted. CPB circuitry was redesigned to achieve significantly less prime volume.
Results: The proportion of patients transfused with
red blood cells was 56% (n =154) in the control group and
reduced by 26.8% in the study group (29.2%; 71 patients;
P < .01). Blood transfusion rate (1.7 ± 1/3.05 ± 1 units), postoperative hemorrhage (545 ± 50/ 775 ± 55 mL), respiratory
support duration (12.4 ± 7/16.8 ± 8 h) and ICU stay (2.2±1.1/
3.5±1.2 days) were significantly better in the blood conservation group.
Conclusion: These findings, in addition to risks and side
effects of blood transfusion and the rising cost of safer blood
products, justify blood conservation in adult cardiac operations.
INTRODUCTION
Despite the recent introduction of a number of technical and pharmacologic blood conservation measures, bleeding and allogeneic transfusion remain persistent problems in
open-heart surgical procedures. The use of blood products
carries several risks, such as immunologic sensitization, anaphylactic reaction, and disease transmission. The underlying
pathophysiology has not been described entirely; however,
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there is evidence on the activation of inflammatory genes
and cytokines in circulating leukocytes with transfusion of
red blood cells [Escobar 2007]. Efforts should be made to
decrease or completely avoid transfusions to avoid these
negative reactions.
In an effort to reduce the negative impact of CPB on
the adult population outcome, the minimized systems were
developed to significantly reduce the hemodilution of the
patient and reduce the foreign surface area that comes in continuous contact with the patient circulating blood volume.
Reducing the size of the perfusion apparatus has two obvious
and immediate effects: first, a reduction in the contact surface
area for potential blood-biomaterial contact; and second, a
reduction in priming volume requirement-less hemodilution
with a consequential reduction in perioperative hematocrit
[Gunaydin 2009].
There is wide variation in the prevalence of perioperative
transfusions in cardiac surgery. A 2013 audit of cardiac surgical units in the United Kingdom identified a threefold variation (22-67%) in the number of patients receiving at least
one unit of blood perioperatively [Murphy 2013]. Variation
in blood usage and the need to balance risks and benefits have
encouraged the use of pragmatic and evidence-based strategies to optimize blood component administration.
The large differences between institutions cannot be
explained just by differences in patient characteristics. Most
likely, institutional and individual differences in transfusion
practice, guidelines, and attitudes influence the frequency and
number of transfusions. The decision to transfuse is based
on multiple patient factors and it is impossible to designate
a single transfusion trigger. The high prevalence initiated a
multifactorial blood conservation program with the intention
of reducing transfusions without compromising patient safety
[Arnold 2006].
The World Health Organization encourages all member
states to implement Patient Blood Management programs
employing multiple combined strategies to increase and preserve autologous erythrocyte volume in order to minimize
unnecessary exposure to RBC transfusions [Farmer 2013].
The aim of this retrospective study was to evaluate the
efficacy of a structured program to reduce transfusions and
transfusion-associated complications in adult cardiac surgery.
PATIENTS AND METHODS
After institutional review board approval (14/227-2) in a
tertiary cardiac center, the coronary artery bypass grafting
(CABG) database was reviewed retrospectively and a total of
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Table 1. Preoperative Characteristics of the Patients

Table 2. Significant Predictors of Alllogeneic Transfusions

Blood Management

Control

Group 1 (n = 243)

Group 2 (n = 275)

P

69.4 ± 10

66.1 ± 10

>.05

Sex (male)

117

126

>.05

BSA (m2)

1.69 ± 0.05

1.73 ± 0.05

>.05

Preop EF (%)

0.45 ± 0.08

0.48 ± 0.08

>.05

EuroSCORE

6.6 ± 2.3

6.9 ± 1.5

>.05

Anti-platelet therapy, n

195

204

>.05

CADX1

17

14

>.05

CADX2

64

73

>.05

CADX3

69

79

>.05

CADx4+

93

109

.036

Age

BSA indicates body surface area; EF, ejection fraction detected by echocardiography; CAD, coronary artery disease.

243 patients who underwent cardiac surgery with cardiopulmonary bypass (CPB) (Group 1: blood conservation) were
studied in a 12-month period (January-December 2016) after
the implementation of the new program, and compared with
275 patients (Group 2: control−no blood conservation) of the
previous 12-month period.
The outcome (dependent-variable) was stated as blood
transfusion. Independent variables were identified.
Exclusion criteria consisted of known coagulopathy and
endocarditis. Patients on anti-platelet therapy preoperatively
received the same protocol. The remainder of the patients who
did not have the exclusion criteria were included in the study.
The blood conservation program was designed as follows:
Education: All the staff involved in the care of the patients,
including surgeons, anesthetists, residents, OR-, ICU- and
ward nurses, nurse helpers, physiotherapists and perfusionists
were educated about the risks and benefits of blood transfusions and the new transfusion guidelines in a 45-minute
lesson. The lesson was repeated for all new employees.
Guidelines: We revised our guidelines for transfusions
based on the Society of Thoracic Surgeons Guidelines [Senay
2009]. In the institutional guidelines, the decision to transfuse
red cells perioperatively should be based on clinical judgment
of the patient’s clinical and hemodynamic status. Generally,
patients were supposed to receive red blood cells if they had
a hematocrit level of <20%, mixed venous oxygen saturation
<60% and regional cerebral oxygenation (rSO2) <50%. The
final decision to transfuse or not was always at the discretion
of the physician responsible.
Transfusion log: A specific transfusion log was added
to the patient records. In this log, all transfusion episodes
were registered together with time of transfusion, indication
for transfusion, type of blood product, amount (units), and
patient status including blood pressure, pulse, mixed venous
oxygenation, hematocrit levels and the prescribing physician.
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Odds Ratio

Confidence Interval

Multivariate P

Lower body surface
area

2.160

1.200-8.4

.0023

Lower preoperative
hematocrit

2.3

1.100-6.500

.0045

Lower red blood cell
mass

1.1

0.850-0.970

.076

Increased total crystalloid volume

3.6

1.2-8.5

.041

Conventional circuit
size

3.1

1.290-8.540

.047

Increased postoperative bleeding in 24 h

4.7

1.150-7.150

.0034

Risk Factors

Reduction in IV fluid volume: We initiated a series
of measures aimed at reducing hemodilution volume. All
sources and volumes of IV fluid were obtained from the
medical record.
CPB circuit design: significantly less prime volume via
oxygenator with integrated arterial filter, condensed circuit,
pole mounted vents, microplegia, ultrafiltration, use of cerebral oxymetry-rSO2, retrograde autologous priming, vacuum
assisted venous drainage, and cell salvage of the residual blood
from the circuit without treatment.
Operative Technique
As a part of the blood conservation program, the bypass
circuit was aseptically assembled using a low-prime integrated
oxygenator and reservoir (Fx15, Terumo Medical Corporation, Ann Arbor, MI, USA) in Group 1 and a Terumo System
1 pump console. All of the roller heads of the pump were
remotely mounted to minimize tubing length and circuit surface area. Isothermic blood cardioplegia was administered
directly into the aorta at the surgical field using premixed
syringes of a 1:4 hyperkalemic solution (1 part blood: 4 parts
crystalloid) (Pharmedium, Portland, OR, USA). The static
prime volume for the circuit was approximately 250 mL.
As part of our previous routine, the control group consisted
of a conventional oxygenator and reservoir (Sorin, Arvada,
CO, USA) that has a static priming volume of 450 mL.
Anticoagulation status was monitored using the Medtronic
HMS+ (Medtronic, Minneapolis, MN, USA) system. Samples of blood for measuring activated clotting times (ACT)
and heparin concentrations were drawn every 30 minutes on
CPB. Adequate anticoagulation was defined as ACT greater
than 500 seconds and heparin concentration assays greater
than or equal to 3.0 mg/kg, as measured by the HMS+ device.
Midazolam, sevoflurane, fentanyl, and norcuronium were
used as anesthetic agents.
After median sternotomy, the patient was systemically
anticoagulated using 339 units/kg of intravenous heparin.
The pulse pressure was verified and retrograde autologous
priming (RAP) was initiated.
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Table 3. Perioperative Outcome
Blood Conservation

Control

Group 1

Group 2

P

90.4 ± 46

92 ± 42

.98

Duration of x-clamp, min

54.4 ± 16

62.2 ± 17

.94

t-intub, h

12.4 ± 7*

16.8 ± 8

.044

Postop hemorrhage, mL

545 ± 50*

775 ± 55

.046

1.7 ± 1*

3.05 ± 1

.015

Inotropic support, n

75(37.8%)*

115 (56%)

.017

ICU stay, day

2.2 ± 1.1*

3.5 ± 1.2

.045

6.4 ± 3

7.5 ± 4

.065

−

2

.24

Duration of CPB, min

Blood transfusion, unit

Hospital stay, day
Mortality, n

Vacuum-assisted venous drainage was utilized to allow
for the use of the smaller venous cannula and venous circuit.
Upon initiation of bypass, crystalloid in the venous line was
diverted into a collection bag and discarded. Full flow to the
patient was achieved with no hemodynamic instability within
five minutes of aortic cannulation.
CPB flow was maintained at 125-150 mL/kg/minute.
Moderate hypothermia (28-34°C) and alpha stat blood gas
management were used.
After the surgical procedure, the heart was aggressively deaired. The aortic cross-clamp was removed and the patient
was systemically rewarmed to normothermia. A second blood
gas was drawn to ensure proper electrolyte balance prior to
termination of CPB support. The resultant hematocrit was
around 20%. Continuous ultrafiltration was performed while
the patient was on CPB. Circuit integrity was maintained
until the patient was transported to the pediatric intensive
care unit.
Perioperative Follow-up
For each patient, the following factors were evaluated
before discharge and documented:
Hemodynamic parameters, perfusion and cross-clamp
duration, intubation period, postoperative hemorrhage, use
of blood (as units) during the hospital stay, use of inotropic
support, complications and infection, the duration of ICU
stay and hospital stay, perioperative mortality. A comparison
between groups was performed retrospectively.
Blood Samples and Assays
Complete blood count (hemoglobin, hematocrit, erythrocyte, white blood cell [WBC] and platelet counts) was
recorded. Results of standard blood and urine chemistry
were documented.
Statistical Analysis
Data was expressed as the mean ± standard error of the
mean. Analysis of variance for comparison of parameters
with normal distribution, and Mann Whitney U test for
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comparison of parameters without normal distribution were
used. Univariate analysis was performed on a large number of
preoperative and intraoperative variables in our database to
identify those variables that might be associated with allogeneic blood. They were entered into a stepwise multiple logistic regression analysis to select the ones that were significant
independent predictors of the need for transfusion. Data were
analyzed using SPSS program.
RESULTS
Preoperative evaluation of groups is summarized in Table 1.
The two groups were generally comparable preoperatively.
Preoperative physical and laboratory evaluation revealed
no difference between patient groups. A list of variables
that were screened for possible association with transfusion
(dependent variable: transfused allogeneic blood) and significant predictors of allogeneic transfusions are listed in Table 2.
The proportion of patients transfused with red blood cells
was 56% (n = 154) in the control group and reduced by 26.8%
in the study group (29.2%; 71 patients; P < .01).
Perioperative outcome is listed in Table 3.
DISCUSSION
Our main motive for organizing a structured patient blood
management program was to document that the proportion
of patients transfused with red blood cells was 56%. This was
not acceptable. All staff (surgeon, anesthesiologists, nurses,
and perfusionists) remained the same. Our target was to
diminish transfusion without compromising patient safety.
We published several CPB-related blood preservation
studies before and demonstrated the positive impact of each
strategy separately [Gourlay 2008; Gunaydin 2011; McCusker
2006; Senay 2009]. In this project, we implemented whatever we thought we could benefit from. Our main prospect
was to employ novel CPB techniques that would result in
less hemodilution.
CPB-related technologies for targeting blood preservation
were all confirmed on an evidence-based level in recent guidelines [Ferraris 2011]: Condensed CPB circuit as Class I-A;
microplegia as Class IIb-B; vacuum-assisted venous drainage
as Class IIb-C; retrograde autologous priming as Class IIb-B
and ultrafiltration as Class IIa. A multi-disciplinary blood
conservation program was also cited as Class IIa evidence.
One of the greatest benefits of the low prime condensed
circuits is in the reduction of CPB prime by eliminating an
external arterial line filter and the associated filter bypass
loop and extra tubing needed to encompass the use of an arterial line filter. The elimination of an external arterial filter
has not only reduced the overall CPB surface area but has
also allowed us to decrease our overall prime volumes. This
has been accomplished through a reduction in static prime
volume and also by allowing placement of the oxygenator
closer to the patient.
In our series, for the blood conservation group, the proportion of patients transfused with red blood cells was 56%
(n = 154) in the control group and reduced by 26.8% in the
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study group (29.2%; 71 patients, P < .01). Blood transfusion
rate (1.7 ± 1/3.05 ± 1 units), postoperative hemorrhage (545 ±
50/ 775 ± 55 mL), respiratory support duration (12.4 ± 7/16.8
± 8 h), and ICU stay (2.2 ± 1.1/ 3.5 ± 1.2 days) were significantly better in the blood conservation group.
We studied thorough variables related to the preoperative
and intraoperative period and demonstrated that the most
significant risk factors for transfusion were body surface area
(OR: 2.16), preoperative hematocrit (OR: 2.3), red blood cell
mass (OR: 1.1), total crystalloid volume (OR: 3.6), conventional circuit (OR: 3.1), and postoperative bleeding in 24 h
(OR: 4.7). The results of the present study demonstrate that
a structured blood conservation program reduces transfusion
prevalence and this can be achieved without compromising
patient safety.
Several public-based blood management initiatives are in
progress to optimize utilization of RBC concentrates [Menkis
2012]. However, none of these initiatives are designed to
provide scientific data in terms of safety issues. Thus, a large
study with robust and relevant clinical endpoints is required.
The objective of this study is to demonstrate that the implementation of a patient blood management program is safe
and achievable.
Our study is a retrospective study and this is one of the
main limitations of the design. We accept this data as preliminary to build a strategy and started a newer protocol and
assessment based on current outcomes obtained from retrospective evaluation and long-term clinical outcome. We
accept that using historic data as a control group in such a
comparative study has less power. But we made every effort
to match both databases to make a comparison as much as
is logical.
In order to continue to improve surgical outcomes, we
must continue to ask the correct questions and attempt to
answer them with the appropriate studies. Our patient population is small. That may be a reason not to get clear significant differences in most of the clinical parameters.
Our results confirm that transfusion of red blood cells during
CPB may cause an undesirable clinical outcome. It is obvious
that blood management with multiple strategies is valid for
an adult population. Hemodilution becomes more important
in lower body surface area. We believe novel CPB technologies may positively contribute to blood management strategies
regarding adult patients undergoing open-heart surgery.
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